hepat
c
viru
hcv
infect
major
global
health
problem
estim
million
infect
individu
worldwid
hcv
envelop
positivestrand
rna
viru
belong
hepaciviru
genu
flavivirida
famili
hcv
infect
seriou
caus
chronic
hepat
hepat
steatosi
liver
cirrhosi
eventu
hepatocellular
carcinoma
decad
antihcv
vaccin
avail
therapeut
option
still
limit
current
standard
therapi
base
pegyl
interferon
ribavirin
partial
effect
result
sustain
virolog
respons
svr
patient
consider
side
effect
recent
hcv
proteas
inhibitor
inhibitor
approv
clinic
use
svr
rate
improv
reach
higher
howev
therapi
quit
expens
probabl
access
patient
worldwid
reason
develop
new
class
safe
inexpens
antivir
compound
improv
efficaci
still
need
treatment
hcv
infect
recent
natur
antimicrobi
peptid
amp
attract
attent
therapeut
agent
varieti
microb
includ
antibioticsresist
strain
amp
share
certain
common
featur
small
peptid
amino
acid
residu
contain
posit
charg
residu
amphipath
structur
peptid
exhibit
broad
spectrum
antivir
antibacteri
activ
direct
indirect
microbicid
activ
amp
isol
venom
anim
includ
scorpion
scorpion
venom
consist
cocktail
biolog
activ
peptid
repres
tremend
potenti
use
drug
design
develop
scorpion
venom
peptid
compos
amino
acid
residu
certain
protein
enzym
consist
residu
scorpion
venom
peptid
show
vast
array
biochem
activ
pharmacolog
function
classifi
two
class
ie
disulfidebridg
nondisulfidebridg
peptid
amp
found
scorpion
venom
paid
attent
due
uniqu
biolog
activ
potenti
use
broadspectrum
antivir
agent
scorpion
venom
amp
posit
charg
amphipath
peptid
divid
three
structur
categori
cystein
contain
peptid
disulfid
bridg
ii
peptid
amphipath
lack
cystein
residu
iii
peptid
rich
certain
amino
acid
prolin
glycin
list
egyptian
scorpion
current
includ
speci
classifi
genera
within
four
differ
famili
buthida
diplocentrida
euscorpiida
scorpionida
present
studi
screen
crude
venom
obtain
five
egyptian
scorpion
speci
leiuru
quinquestriatu
androctonu
amoreuxi
australi
bicolor
scorpio
mauru
palmatu
possibl
antihcv
activ
use
hcv
cell
cultur
system
report
crude
venom
mauru
palmatu
australi
lesser
extent
possess
antivir
activ
hcv
knowledg
first
report
describ
antihcv
activ
egyptian
scorpion
venom
antihcv
activ
crude
venom
five
egyptian
scorpion
speci
test
shown
tabl
australi
mauru
palmatu
show
antihcv
activ
respect
respect
select
index
si
respect
crude
venom
three
scorpion
speci
exhibit
signific
antihcv
activ
concentr
dosedepend
antihcv
activ
mauru
palmatu
shown
figur
explor
mode
action
mauru
palmatu
venom
timeofaddit
experi
perform
brief
mauru
palmatu
crude
venom
ad
viru
andor
cell
differ
time
point
rel
viru
inocul
describ
method
section
pretreat
cell
hr
hr
cell
experi
examin
whether
interact
venom
cell
ii
pretreat
viru
hr
hr
viru
experi
examin
possibl
virocid
activ
venom
iii
cotreat
cell
viru
viru
inocul
hr
hr
experi
examin
antivir
effect
entri
step
iv
treatment
virusinfect
cell
postinocul
hr
hr
experi
examin
antivir
effect
postentri
step
v
cotreat
postinocul
hr
hr
posit
control
set
experi
hcv
infect
cultur
supernat
determin
compar
result
reveal
pretreat
viru
hr
hr
viru
markedli
suppress
product
hcv
infecti
particl
cultur
supernat
pretreat
cell
hr
hr
cell
margin
suppress
figur
suggest
possibl
mauru
palmatu
venom
direct
virocid
activ
also
treatment
postinocul
hr
hr
suppress
hcv
infect
cultur
supernat
though
lesser
extent
compar
pretreat
viru
hr
hr
viru
result
suggest
treatment
inhibit
either
hcv
replic
cell
hcv
infect
outsid
cell
cultur
supernat
hand
treatment
postinocul
hr
hr
significantli
inhibit
hcv
protein
accumul
pretreat
viru
hr
hr
viru
complet
inhibit
day
postinfect
figur
examin
hcv
rna
replic
viru
infect
insid
cell
result
reveal
postinocul
treatment
hr
significantli
inhibit
hcv
rna
replic
cell
figur
moreov
venom
treatment
hr
reduc
hcv
infect
insid
cell
figur
taken
togeth
result
suggest
mauru
palmatu
venom
act
directli
hcv
particl
cultur
medium
impair
viral
infect
exert
antivir
effect
insid
cell
order
investig
whether
antihcv
activ
mauru
palmatu
venom
involv
enzymat
activ
treat
venom
heat
min
metalloproteinas
inhibitor
mm
inactiv
report
investig
treat
venom
ad
hcv
incub
hr
virusvenom
mixtur
inocul
cell
viru
replic
analyz
result
obtain
reveal
treat
venom
either
treat
heat
metalloproteinas
inhibitor
time
still
markedli
suppress
product
hcv
infecti
particl
cultur
extent
compar
untreat
control
figur
consist
observ
accumul
intracellular
hcv
protein
also
inhibit
figur
order
determin
whether
antivir
activ
mauru
palmatu
venom
shown
specif
hcv
examin
possibl
effect
differ
virus
dengu
viru
type
measl
viru
influenza
viru
analysi
viru
pretreat
venom
hr
remain
viru
infect
measur
infecti
center
plaqu
assay
result
reveal
venom
exert
weak
inhibit
measl
viru
strong
inhibit
dengu
viru
figur
interestingli
venom
inhibit
rather
enhanc
infect
influenza
viru
figur
venom
anim
includ
scorpion
evolv
wide
varieti
peptid
toxin
purpos
predat
defens
scorpion
venom
rich
sourc
natur
peptid
recogn
potenti
bioactiv
peptid
cdna
librari
sequenc
proteom
profil
analys
reveal
singl
scorpion
venom
contain
peptid
compon
rang
size
kda
increas
number
studi
shown
scorpion
venom
toxin
possess
antivir
activ
vitro
vivo
consid
rich
sourc
develop
effect
antivir
drug
present
studi
screen
crude
venom
obtain
five
egyptian
scorpion
speci
possibl
antihcv
activ
observ
crude
venom
mauru
palmatu
australi
possess
antihcv
activ
valu
respect
tabl
also
demonstr
mauru
palmatu
venom
act
directli
hcv
particl
cultur
supernat
inhibit
viral
infect
figur
suggest
inhibit
entri
step
first
step
hcv
life
cycl
hand
unlik
venom
exert
antivir
activ
insid
cell
figur
scorpion
venom
contain
wide
varieti
pharmacolog
activ
peptid
protein
possess
enzymat
activ
metalloproteas
other
nonenzymat
constitu
report
proteolyt
activ
enzym
almost
complet
abolish
treatment
matrix
metalloproteinas
inhibitor
also
enzymat
activ
known
inactiv
heat
min
made
use
inform
studi
observ
treatment
mauru
palmatu
venom
andor
heat
min
impair
antihcv
activ
figur
result
suggest
antihcv
activ
mauru
palmatu
venom
independ
proteinas
activ
concern
molecular
mechan
antihcv
activ
possibl
venom
peptid
induc
disrupt
viru
envelop
compos
lipid
bilay
make
pore
case
venom
might
inhibit
envelop
virus
hcv
test
possibl
use
three
differ
virus
dengu
viru
type
anoth
member
famili
flavivirida
measl
viru
influenza
viru
belong
famili
paramyxovirida
orthomyxovirida
respect
result
obtain
demonstr
mauru
palmatu
venom
exert
strong
inhibit
dengu
viru
weak
inhibit
measl
viru
figur
hand
venom
inhibit
rather
enhanc
influenza
viru
infect
figur
result
exclud
possibl
mauru
palmatu
venom
inhibit
envelop
virus
suggest
venom
preferenti
inhibit
hcv
dengu
viru
belong
famili
flavivirida
virus
eg
influenza
viru
mauru
palmatu
venom
report
contain
compound
whose
molecular
mass
vari
da
major
rang
kda
varieti
put
bioactiv
molecul
identifi
neurotoxin
nasctx
ksctx
calcin
peptid
insecticid
toxin
amp
scorpion
venom
peptid
show
antivir
activ
certain
virus
measl
viru
sar
coronaviru
influenza
viru
hepat
b
viru
herp
simplex
viru
human
immunodefici
viru
antihcv
peptid
scorpion
venom
yan
et
al
report
screen
venom
gland
cdna
librari
scorpion
heterometru
petersii
inhibit
hcv
infect
target
viral
membran
disrupt
structur
integr
also
hong
et
al
identifi
anoth
antihcv
peptid
venom
peptid
librari
scorpion
chaerilu
tryznai
peptid
exert
virocid
effect
hcv
virus
consist
result
observ
mauru
palmatu
venom
inhibit
infect
hcv
particl
suggest
direct
virocid
activ
venom
interestingli
antivir
activ
mauru
palmatu
venom
like
preferenti
direct
hcv
dengu
viru
member
famili
flavivirida
studi
use
bioactivityguid
fraction
purif
analys
need
identifi
activ
compound
respons
antivir
activ
screen
crude
venom
obtain
five
egyptian
scorpion
speci
antihcv
activ
demonstr
mauru
palmatu
venom
inhibit
hcv
infect
direct
virocid
activ
addit
antivir
activ
appear
independ
proteinas
activ
venom
direct
preferenti
hcv
equal
envelop
virus
knowledg
first
report
describ
antivir
activ
egyptian
scorpion
venom
hcv
open
new
approach
toward
discov
antivir
compound
deriv
scorpion
venom
adult
scorpion
collect
differ
place
egypt
fed
cockroach
receiv
water
venom
obtain
scorpion
use
electr
stimul
v
surgic
separ
venom
gland
smaller
scorpion
milk
venom
squeez
eppendorf
tube
use
fine
forcep
solubil
distil
water
crude
venom
thu
obtain
centrifug
rpm
min
supernat
pool
freezedri
store
lyophil
sampl
dissolv
distil
water
centrifug
rpm
min
supernat
store
use
protein
concentr
sampl
determin
use
bca
protein
assay
kit
pieric
biotechnolog
usa
cell
plasmid
produc
strain
hcv
genotyp
kindli
provid
dr
c
rice
rockefel
univers
new
york
ny
usa
cell
cultiv
dulbecco
modifi
eagl
medium
wako
osaka
japan
supplement
fetal
bovin
serum
biowest
nuaill
franc
nonessenti
amino
acid
invitrogen
carlsbad
ca
usa
penicillin
iuml
streptomycin
invitrogen
cell
grown
incub
strain
hcv
genotyp
propag
cell
use
studi
dengu
viru
type
trinidad
strain
propag
cell
inocul
veroslam
cell
viru
adsorpt
hr
virusinfect
cell
cultiv
dmem
supplement
fetal
bovin
serum
measl
viru
strain
propag
cell
inocul
veroslam
cell
viru
adsorpt
hr
virusinfect
cell
cultiv
describ
influenza
viru
inocul
madindarbi
canin
kidney
mdck
cell
min
ice
virusinfect
cell
cultiv
minimum
essenti
medium
mem
life
technolog
tokyo
japan
contain
tpcktrypsin
worthington
biochem
corp
lakewood
nj
usa
unitsml
penicillin
streptomycin
gibco
gland
island
ny
usa
cell
seed
plate
cellswel
fix
amount
hcv
mix
serial
dilut
crude
venom
inocul
cell
hr
cell
wash
medium
remov
residu
viru
incub
medium
contain
concentr
crude
venom
use
viru
inocul
cultur
supernat
obtain
day
postinfect
dpi
titrat
viru
infect
viru
cell
treat
medium
serv
control
percent
inhibit
viru
infect
sampl
calcul
compar
control
inhibitori
concentr
determin
hcv
infect
determin
describ
previous
brief
viru
sampl
dilut
serial
complet
medium
inocul
onto
cell
seed
glass
coverslip
plate
viru
adsorpt
hr
cell
wash
medium
remov
residu
viru
cultur
hr
virusinfect
cell
wash
phosphatebuff
salin
pb
fix
paraformaldehyd
min
permeabil
triton
pb
min
room
temperatur
wash
three
time
pb
cell
incub
hcvinfect
patient
serum
hr
follow
incub
fitcconjug
goat
antihuman
igg
medic
biolog
laboratori
co
ltd
nagoya
japan
cell
counterstain
hoechst
molecular
probe
eugen
usa
min
hcvinfect
cell
count
fluoresc
microscop
keyenc
osaka
japan
determin
intracellular
hcv
infect
freezeandthaw
experi
perform
brief
virusinfect
cell
wash
pb
harvest
trypsin
treatment
centrifug
rpm
min
cell
pellet
obtain
resuspend
fresh
medium
subject
cycl
freez
thaw
thermo
block
respect
sampl
centrifug
rpm
min
remov
cell
debri
hcv
infect
measur
immunofluoresc
stain
describ
determin
dengu
viru
infect
serial
dilut
viru
inocul
veroslam
cell
cultiv
hr
cell
subject
indirect
immunofluoresc
analysi
use
mous
monoclon
antibodi
dengu
viru
follow
alexa
fluor
goat
antimous
igg
life
technolog
describ
number
infect
cell
count
measl
viru
inocul
veroslam
cell
cultiv
hr
plaqu
virusinduc
syncytia
form
monolay
cell
count
influenza
viru
inocul
mdck
cell
cultiv
hr
cell
fix
paraformaldehyd
min
follow
cold
methanol
min
room
temperatur
fix
cell
incub
min
rabbit
polyclon
antibodi
rais
purifi
influenza
viru
strain
two
wash
cell
incub
min
alexa
fluor
goat
antirabbit
igg
life
technolog
hoechst
counterstain
nuclei
cell
coverslip
mount
slide
glass
vectashield
reagent
vector
laboratori
inc
burligam
ca
observ
use
fluoresc
microscop
crude
venom
ad
final
concentr
viru
cell
differ
time
point
rel
viru
inocul
five
set
experi
perform
parallel
pretreat
cell
hr
cell
venom
ad
cell
hr
follow
wash
two
time
medium
viru
infect
incub
medium
without
venom
hr
ii
pretreat
viru
hr
viru
viru
mix
venom
hr
mixtur
inocul
cell
hr
virusvenom
mixtur
remov
wash
two
time
cell
incub
medium
without
venom
hr
iii
cotreat
cell
viru
viru
inocul
hr
virusvenom
mixtur
inocul
cell
incub
hr
virusvenom
mixtur
remov
wash
two
time
cell
incub
medium
without
venom
hr
iv
treatment
postinocul
hr
cell
infect
viru
hr
absenc
venom
viru
remov
wash
two
time
cell
incub
medium
contain
venom
hr
v
cotreat
inocul
postinocul
hr
hr
posit
control
virusvenom
mixtur
inocul
cell
incub
hr
virusvenom
mixtur
remov
wash
two
time
cell
incub
medium
contain
venom
hr
set
experi
supernat
collect
titrat
viru
infect
also
cell
subject
immunoblot
analysi
intracellular
accumul
viral
host
protein
assay
perform
describ
previous
slight
modif
brief
cell
plate
plate
treat
serial
dilut
crude
venom
complet
medium
control
hr
treatment
reagent
roch
mannheim
germani
ad
well
cell
cultur
hr
reagent
absorb
cell
convert
formazan
mitochondri
dehydrogenas
amount
formazan
correl
number
live
cell
determin
measur
absorb
well
use
micropl
reader
nm
percent
cell
viabil
compar
control
calcul
dilut
venom
cytotox
concentr
determin
cell
lyse
sd
sampl
buffer
equal
amount
protein
subject
gel
electrophoresi
separ
protein
transfer
onto
polyvinyliden
difluorid
membran
millipor
bedford
usa
membran
block
incub
skim
milk
incub
respect
primari
antibodi
primari
antibodi
use
mous
monoclon
antibodi
hcv
gapdh
millipor
horseradish
peroxidaseconjug
goat
antimous
immunoglobulin
invitrogen
use
visual
respect
protein
mean
enhanc
chemiluminesc
detect
system
ecl
ge
healthcar
buckinghamshir
uk
total
rna
extract
cell
use
reliaprep
rna
cell
miniprep
system
promega
madison
wi
usa
accord
manufactur
instruct
one
total
rna
revers
transcrib
use
goscript
revers
transcript
system
promega
random
primer
subject
quantit
realtim
pcr
analysi
use
sybr
premix
ex
taq
takara
kyoto
japan
microamp
reaction
plate
abi
prism
system
appli
biosystem
foster
citi
ca
usa
primer
use
amplifi
region
hcv
genom
sens
ccgcagcgacggtgct
antisens
intern
control
human
dehydrogenas
gapdh
gene
express
level
measur
use
primer
sens
crude
venom
heat
min
treat
metalloproteas
inhibitor
mm
min
treat
venom
untreat
control
mix
hcv
hr
virusvenom
mixtur
inocul
cell
hr
viru
inocul
cell
wash
three
time
incub
medium
without
venom
hr
cultur
supernat
collect
viru
infect
titrat
virusinfect
cell
subject
immunoblot
analysi
check
level
hcv
protein
accumul
describ
data
repres
least
independ
repeat
experi
present
mean
sem
statist
signific
examin
use
student
ttest
p
valu
consid
signific
